cataract with diabetic macular edema
Conditions
Interventions
experimental group:Phacoemulsification for cataract + intravitreal Conbercept injection
Control group:Phacoemulsification for cataract
Sponsors
the 4th affiliated hospital of CMU
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: the cataract patients combined with diabetic macular edema, the lens nuclear hardness is in the degree of three, OCT show retinal thickness of macular is greater than 300um, fundus angiography showed that patients with diabetic retinopathy staging is moderate, mild macular edema without ischemic; if both of the eyes are consistent with inclusion criteria, the doctor choose the one eye according to the medical point of view.The control standard of glycosylated hemoglobin was less than 6.5%, the blood glucose was lower than 8mol/L before the meals, and the blood pressure should be less than 160/90mmHg.
Exclusion criteria
Exclusion criteria: 1. the patient contraindicated to FFA; 2. suffer from other macular diseases previously such as age-related macular degeneration, central serous retinopathy; 3. nearly 3 months were treated with glucocorticoid and other anti VEGF drug treatment; 4. combined with anterior segment disease of eyes; 5. the patients with serious heart, brain and liver kidney and hematopoietic system diseases; 6. the patients with malignant tumor; 7. the diopter is higher than 6D.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BCVA;protein concentration in aqueous humor;retinal thickness of macular;IOP; | — |
Countries
China
Contacts
Public ContactZhang Jinsong
Outcome results
None listed